SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

We have one operating segment: the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Our entire business is managed by a single management team, which reports to our Chief Executive Officer. For the three months ended September 30, 2014 and 2013, we generated approximately 94% and 95% of revenues, respectively, within the U.S., and for the nine months ended September 30, 2014 and 2013, we generated approximately 92% and 94% of revenues, within the U.S. As of September 30, 2014 and December 31, 2013, substantially all of our long-lived assets were held within the U.S.